BioInformant Worldwide, L.L.C.
BioInformant Worldwide, LLC, situated in the United States, is a distinguished research entity specializing in delivering market intelligence tailored for the dynamic stem cell industry. Uniquely positioned, they stand as the sole company dedicated to serving the stem cell sector since its inception. This distinctive focus empowers them to generate comprehensive data that equips clients with enhanced insights into markets, competitors, and customer dynamics.
Over time, BioInformant has earned notable recognition, having been prominently featured in renowned news outlets such as Nature Biotechnology, the Wall Street Journal, CBS News, Yahoo Finance, Medical Ethics, MarketWatch, the Center for BioNetworking, and various others.
The leadership team at BioInformant possesses a background in BioInformatics, a discipline centered on intricate genetic code collection and analysis. Their adeptness in applying these advanced data analysis techniques to market research solidifies their standing in the industry.
Functioning as a dedicated stem cell research firm, BioInformant leverages cutting-edge technology to track and pinpoint lucrative prospects within the stem cell domain. This invaluable data is then furnished to clients striving for aggressive expansion. Serving influential entities including GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, Thermo Fisher Scientific, and numerous others among the Fortune 500, BioInformant stands as the trusted purveyor of authoritative stem cell industry insights.
|
|
List of reports from BioInformant Worldwide, L.L.C.
|
|
|
|
|
|
|
|
|
|
|
|
|
USD 4,497
|
|
USD 4,297
|
|
USD 4,497
|
|
USD 4,497
|
The Global Market for Cultured Meat – Market Size, Trends, Competitors, and Forecasts (2022)
9/1/2022 | published by: BioInformant Worldwide, L.L.C.
... produced by growing master cells collected from cattle, chicken, pigs, fish, and lamb, as well as other types of livestock and seafood. In addition to meat and seafood production, cultured meat techniques can be used ...
|
read more...
|
USD 4,197
|
|
USD 4,497
|
Mesenchymal Stem Cells - Advances and Applications, 2022
4/1/2022 | published by: BioInformant Worldwide, L.L.C.
... and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types for ...
|
read more...
|
USD 3,997
|
|
USD 3,997
|
Global Cord Blood and Tissue Banking Industry Report 2021
11/1/2021 | published by: BioInformant Worldwide, L.L.C.
... therapeutic and financial reasons, the cord blood industry has been witnessing record levels of merger and acquisition (M&A) activity in recent years, with market leaders gaining market share at the expense of smaller competitors and ...
|
read more...
|
USD 3,997
|
The Global Exosome Market – Market Size, Forecast, Trials, and Trends, 2021
8/1/2021 | published by: BioInformant Worldwide, L.L.C.
... they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely ...
|
read more...
|
USD 3,997
|
|
USD 3,997
|
Mesenchymal Stem Cells - Advances and Applications, 2021
8/1/2021 | published by: BioInformant Worldwide, L.L.C.
... and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types for ...
|
read more...
|
USD 3,997
|
|
USD 1,297
|
|
USD 4,797
|
|
USD 3,997
|
The Global Exosome Market – Market Size, Forecast, Trials, and Trends, 2021
5/15/2021 | published by: BioInformant Worldwide, L.L.C.
... they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely ...
|
read more...
|
USD 3,997
|
Global Cord Blood Banking Industry Report 2021
1/5/2021 | published by: BioInformant Worldwide, L.L.C.
... From 2005 to 2010, the market reached saturation and stabilized. From 2010 to 2020, the market began to aggressively consolidate, creating both threats and opportunities within the industry. Serious threats to the industry include low ...
|
read more...
|
USD 3,997
|
|
US: 800.298.5699 Int'l: +1.240.747.3093
Join Alert Me now! Receive bi-weekly email alerts on new market research Sign up today!
|